Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Titre (en) » - entrée « binding »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
bimodal < binding < binds  Facettes :

List of bibliographic references indexed by binding

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000310 (2011) Rodrigo Carlessi [Israël] ; Vered Levin-Salomon [Israël] ; Sara Ciprut [Israël] ; Shani Bialik [Israël] ; Hanna Berissi [Israël] ; Shira Albeck ; Yoav Peleg ; Adi Kimchi [Israël]GTP binding to the ROC domain of DAP‐kinase regulates its function through intramolecular signalling
000415 (2011) Patrick A. Holt [États-Unis] ; Robert Buscaglia [États-Unis] ; John O. Trent [États-Unis] ; Jonathan B. Chaires [États-Unis]A discovery funnel for nucleic acid binding drug candidates
001196 (2006) Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Stefano Goldwurm [Italie] ; Michela Zini [Italie] ; Roberto Cilia [Italie] ; Paolo Gerundini [Italie] ; Alessio Di Fonzo [Pays-Bas, Italie] ; Vincenzo Bonifati [Pays-Bas, Italie] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie]Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation
001495 (2005) Sathya R. Sriram ; Xiaojie Li ; Han Seok Ko ; Kenny K. K. Chung ; Esther Wong [Singapour] ; Kah Leong Lim [Singapour] ; Valina L. Dawson ; Ted M. Dawson [États-Unis]Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin
001D50 (1999) Yasuomi Ouchi [Japon] ; Toshihiko Kanno [Japon] ; Hiroyuki Okada [Japon] ; Etsuji Yoshikawa [Japon] ; Masami Futatsubashi [Japon] ; Shuji Nobezawa [Japon] ; Tatsuo Torizuka [Japon] ; Masanobu Sakamoto [Japon]Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: A double‐tracer positron emission tomography study
001E11 (1999) Yasuomi Ouchi [Japon] ; Etuji Yoshikawa [Japon] ; Hiroyuki Okada [Japon] ; Masami Futatsubashi [Japon] ; Yoshimoto Sekine [Japon] ; Masaomi Iyo [Japon] ; Masanobu Sakamoto [Japon]Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for β‐CFT binding with positron emission tomography
002189 (1996) W. Oder [Autriche] ; T. Brücke [Autriche] ; H. Kollegger [Autriche] ; J. Spatt [Autriche] ; S. Asenbaum [Autriche] ; L. Deecke [Autriche]Dopamine D2 receptor binding is reduced in Wilson's disease: Correlation of neurological deficits with striatal123I-Iodobenzamide binding
002200 (1996) B. Leveugle [États-Unis] ; B. A. Faucheux ; C. Bouras [États-Unis] ; N. Nillesse ; G. Spik ; E. C. Hirsch ; Yves Agid [France] ; P. R. Hof [États-Unis]Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson’s disease cases
002400 (1994) S. Enochs [États-Unis] ; T. Sarna [Pologne] ; L. Zecca [Italie] ; A. Riley [Royaume-Uni] ; M. Swartz [États-Unis]The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: A hypothesis
002445 (1994) Annick Mouatt-Prigent [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
002458 (1994) E. K. Perry [Royaume-Uni] ; C. M. Morris [Royaume-Uni] ; J. A. Court [Royaume-Uni] ; A. Cheng [Royaume-Uni] ; A. F. Fairbairn [Royaume-Uni] ; I. G. Mckeith [Royaume-Uni] ; D. Irving [Royaume-Uni] ; A. Brown [Royaume-Uni] ; R. H. Perry [Royaume-Uni]Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology
002567 (1993) G. Arnold [Allemagne] ; B. Bondy [Allemagne] ; O. Bandmann [Allemagne] ; Th. Gasser [Allemagne] ; J. Schwarz [Allemagne] ; C. Trenkwalder [Allemagne] ; M. Wagner [Autriche] ; Werner Poewe [Autriche, Allemagne] ; H. Oertel [Allemagne]3H-spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes
002627 (1992) G. Chinaglia [Suisse, Italie] ; F. J. Alvarez [Espagne] ; A. Probst [Suisse] ; J. M. Palacios [Espagne]Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: A quantitative autoradiographic study using [3H]mazindol
002A40 (1984) K. C. Mccullough [Royaume-Uni] ; D. Parkinson [Royaume-Uni]The standardization of a ‘spot-test’ ELISA for the rapid screening of sera and hybridoma cell products II. The determination of binding capacity, binding ratio and coefficient of variation of different ELISA plates in sandwich and indirect ELISA

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "binding" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "binding" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    binding
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024